Literature DB >> 27896825

Is it time to reconsider lobectomy in low-risk paediatric thyroid cancer?

Wouter P Kluijfhout1,2, Jesse D Pasternak1, Danielle van der Kaay3, Menno R Vriens2, Evan J Propst4, Jonathan D Wasserman3.   

Abstract

OBJECTIVE: Current guidelines recommend total thyroidectomy for nearly all children with well-differentiated thyroid cancer (WDTC). These guidelines, however, derive from older data accrued prior to current high-resolution imaging. We speculate that there is a subpopulation of children who may be adequately treated with lobectomy.
DESIGN: Retrospective analysis of prospectively maintained database. PATIENTS: Seventy-three children with WDTC treated between 2004 and 2015. MEASUREMENTS: We applied two different risk-stratification criteria to this population. First, we determined the number of patients meeting American Thyroid Association (ATA) 'low-risk' criteria, defined as disease grossly confined to the thyroid with either N0/Nx or incidental microscopic N1a disease. Second, we defined a set of 'very-low-risk' histopathological criteria, comprising unifocal tumours ≤4 cm without predefined high-risk factors, and determined the proportion of patients that met these criteria.
RESULTS: Twenty-seven (37%) males and 46 (63%) females were included in this study, with a mean age of 13·4 years. Ipsilateral- and contralateral multifocality were identified in 27 (37·0%) and 19 (26·0%) of specimens. Thirty-seven (51%) patients had lymph node metastasis (N1a = 18/N1b = 19). Pre-operative ultrasound identified all cases with clinically significant nodal disease. Of the 73 patients, 39 (53·4%) met ATA low-risk criteria and 16 (21·9%) met 'very-low-risk' criteria. All 'very-low-risk' patients demonstrated excellent response to initial therapy without persistence/recurrence after a mean follow-up of 36·4 months.
CONCLUSIONS: Ultrasound and histopathology identify a substantial population that may be candidates for lobectomy, avoiding the risks and potential medical and psychosocial morbidity associated with total thyroidectomy. We propose a clinical framework to stimulate discussion of lobectomy as an option for low-risk patients.
© 2016 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2017        PMID: 27896825     DOI: 10.1111/cen.13287

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  3 in total

1.  Clinical Course of Early Postoperative Hypothyroidism Following Thyroid Lobectomy in Pediatrics.

Authors:  Julia A Baran; Andrew J Bauer; Stephen Halada; Sogol Mostoufi-Moab; Amber Isaza; Stephanie Robbins; Aime T Franco; N Scott Adzick; Tasleema Patel; Ken Kazahaya
Journal:  Thyroid       Date:  2021-12-02       Impact factor: 6.568

2.  Oncogene-specific inhibition in the treatment of advanced pediatric thyroid cancer.

Authors:  Aime T Franco; Julio C Ricarte-Filho; Theodore W Laetsch; Andrew J Bauer
Journal:  J Clin Invest       Date:  2021-09-15       Impact factor: 19.456

3.  Paediatric differentiated thyroid carcinoma: a UK National Clinical Practice Consensus Guideline.

Authors:  Sasha R Howard; Sarah Freeston; Barney Harrison; Louise Izatt; Sonali Natu; Kate Newbold; Sabine Pomplun; Helen A Spoudeas; Sophie Wilne; Tom R Kurzawinski; Mark N Gaze
Journal:  Endocr Relat Cancer       Date:  2022-09-07       Impact factor: 5.900

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.